Esophageal Ca Survival Jumps with Docetaxel

SAN FRANCISCO (MedPage Today) -- Second-line chemotherapy with docetaxel for esophagogastric cancer led to a greater than 40% improvement in survival compared with only symptomatic treatment, results of a British study showed.
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news